Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Joan C. Mattson"'
Autor:
Maureen A. Smythe, Lindsey R. Corbets, Joan C. Mattson, Elizabeth Conger, Trupti P. Mehta, John M. Koerber, Lisa L. Forsyth
Publikováno v:
Thrombosis and Haemostasis. 108:992-998
SummaryEstablishing the diagnosis of heparin induced thrombocytopenia (HIT) is challenging as laboratory tests for HIT vary in specificity and availability. As HIT suspicion far exceeds confirmation of diagnosis, overtreatment is an emerging concern.
Publikováno v:
European Journal of Haematology. 46:77-84
33 cases of chronic granulocytic leukemia (CGL) were reassessed to determine if, by strict morphologic criteria. Philadelphia chromosome (Ph1)-negative CGL exists as a diagnostic entity and if Ph1-positive CGL could be distinguished from Ph1-negative
Publikováno v:
Chest. 131:1644-1649
Heparin-induced thrombocytopenia (HIT) is estimated to occur in up to 5% of patients receiving unfractionated heparin. The goal was to determine the incidence of HIT within our 1,061-bed tertiary care institution.A retrospective review of three hospi
Publikováno v:
The Journal of Molecular Diagnostics. 8:420-425
Venous thromboembolic events (VTEs) affect an estimated 1 in 1000 people annually, resulting in ∼50,000 deaths, with prevalence increasing with age. The genetic contributors to thrombosis have been described and further explored within the last 15
Publikováno v:
Annals of Pharmacotherapy. 39:28-31
BACKGROUND: Many patients receiving direct thrombin inhibitor (DTI) therapy require transition to warfarin. This transition may be complicated by DTI-induced elevations in the international normalized ratio (INR). While the effect of argatroban on th
Autor:
Sandra N. Nowak, Maureen A. Smythe, Robert L Begle, Joan C. Mattson, Mamtha Balasubramaniam, John M. Koerber, Susan J. Westley
Publikováno v:
Annals of Pharmacotherapy. 36:7-11
OBJECTIVE: To evaluate the correlation between clotting time tests and heparin concentration, the correlation between activated clotting time (ACT) and activated partial thromboplastin time (aPTT) results, and to compare the clinical decisions based
Autor:
Joan C. Mattson, John M. Koerber, Susan J. Westley, Mamtha Balasubramaniam, Maureen A. Smythe
Publikováno v:
Archives of Pathology & Laboratory Medicine. 125:1458-1462
Objective.—To assess the impact of heparin lot on the correlation between heparin concentration and activated partial thromboplastin time (aPTT), the aPTT therapeutic range, and the heparin level. Design.—Retrospective analysis of data from 2 pre
Autor:
Domnita Crisan, Joan C. Mattson, Lelia Yu, Rebecca C. Hankin, Arthur B. Eisenbrey, Bruce H. Davis, Waqar A. Khan, Abdul Al Saadi
Publikováno v:
American Journal of Clinical Pathology. 116:41-50
We describe 2 male patients in whom hepatosplenic gamma/delta T-cell lymphoma (HSTL) developed 6 and 10 years after renal transplantation. The onset was abrupt with systemic symptoms, cytopenia, and hepatosplenomegaly. The histologic examination of t
Autor:
Kurt Neumann, Joan C. Mattson, John A. Friedline, Bruce H. Davis, Ishmael Jaiyesimi, John H. Burdakin, Adnan Al-Khalili, Dana Zakalik, Tibor Gyorfi, Mamtha Balasubramaniam, Freeman Wilner, David A. Decker
Publikováno v:
Leukemia Research. 24:417-426
The outcome of patients diagnosed with primary myelodysplastic syndromes (MDS) between 1990 and 1997 from William Beaumont Hospital (WBH) was analyzed according to the International Prognostic Scoring System (IPSS) risk categorization. A retrospectiv
Autor:
Joan C. Mattson
Publikováno v:
Clinics in Laboratory Medicine. 20:83-103
Acute promyelocytic leukemia is a unique subtype of acute myelogenous leukemia characterized by distinct morphologic, cytogenetic, and clinical characteristics. The t(15;17) translocation, which is a hallmark of this disease, results in a transcripti